Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer.
Marzieh HaghbinAkbar Hashemi TayerMaryam KamravanAbdolreza Sotoodeh JahromiPublished in: Asian Pacific journal of cancer prevention : APJCP (2021)
Increased levels of PMPs and activity in terms of hemostasis and having a positive and significant relationship with tumor grading and metastasis may indicate the effective role of PMPs in the pathogenesis and prognosis of breast cancer.
Keyphrases